Collocation of metformin and dipeptidyl peptidase-4 inhibitor is associated with increased risk of diabetes-related vascular dementia: A single hospital study in Northern Taiwan

MLA

I-Shiang Tzeng, and Tsung-Han Hsieh. “Collocation of Metformin and Dipeptidyl Peptidase-4 Inhibitor Is Associated with Increased Risk of Diabetes-Related Vascular Dementia: A Single Hospital Study in Northern Taiwan.” Expert Opinion on Investigational Drugs, vol. 32, Feb. 2023, pp. 171–76. EBSCOhost, https://doi.org/10.1080/13543784.2023.2178417.

APA

I-Shiang Tzeng, & Tsung-Han Hsieh. (2023). Collocation of metformin and dipeptidyl peptidase-4 inhibitor is associated with increased risk of diabetes-related vascular dementia: A single hospital study in Northern Taiwan. Expert Opinion on Investigational Drugs, 32, 171–176. https://doi.org/10.1080/13543784.2023.2178417

Chicago

I-Shiang Tzeng, and Tsung-Han Hsieh. 2023. “Collocation of Metformin and Dipeptidyl Peptidase-4 Inhibitor Is Associated with Increased Risk of Diabetes-Related Vascular Dementia: A Single Hospital Study in Northern Taiwan.” Expert Opinion on Investigational Drugs 32 (February): 171–76. doi:10.1080/13543784.2023.2178417.